Page last updated: 2024-08-17

dichloroacetic acid and Mouth Neoplasms

dichloroacetic acid has been researched along with Mouth Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, HD; Guo, YZ; Liu, ZS; Wang, PY; Xie, Q; Xie, WL; Zhang, HF	1
Agriesti, F; Capitanio, N; Laurenzana, I; Lo Muzio, L; Mazzoccoli, C; Perrone, D; Piccoli, C; Ruggieri, V; Scrima, R; Tataranni, T	1

Other Studies

2 other study(ies) available for dichloroacetic acid and Mouth Neoplasms

Article	Year
Combination of Taxol® and dichloroacetate results in synergistically inhibitory effects on Taxol-resistant oral cancer cells under hypoxia. Molecular medicine reports, 2015, Volume: 11, Issue:4 Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Dichloroacetic Acid; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Gene Expression; Humans; Mouth Neoplasms; Paclitaxel; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase	2015
Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment. Oncotarget, 2015, Jan-20, Volume: 6, Issue:2 Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Dichloroacetic Acid; Glycolysis; Humans; Immunoblotting; Membrane Potential, Mitochondrial; Mitochondria; Mouth Neoplasms; NAD; Oxidation-Reduction; Oxidative Phosphorylation; Phosphorylation; Pyruvate Dehydrogenase (Lipoamide)	2015

Article

Year

Combination of Taxol® and dichloroacetate results in synergistically inhibitory effects on Taxol-resistant oral cancer cells under hypoxia.

Molecular medicine reports, 2015, Volume: 11, Issue:4

Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Dichloroacetic Acid; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Gene Expression; Humans; Mouth Neoplasms; Paclitaxel; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase

2015

Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.

Oncotarget, 2015, Jan-20, Volume: 6, Issue:2

Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Dichloroacetic Acid; Glycolysis; Humans; Immunoblotting; Membrane Potential, Mitochondrial; Mitochondria; Mouth Neoplasms; NAD; Oxidation-Reduction; Oxidative Phosphorylation; Phosphorylation; Pyruvate Dehydrogenase (Lipoamide)

2015